Heartflow, Inc. (NASDAQ:HTFL) Given Average Recommendation of "Moderate Buy" by Brokerages

Key Points

• Heartflow has a consensus analyst rating of “Moderate Buy” from nine brokerages, with six buy ratings, two holds, and one sell. The average 1-year price target is about $37.67.
• Several firms recently adjusted their views: JPMorgan and Wells Fargo cut price targets to $35, while Canaccord Genuity raised its target to $43 and William Blair initiated coverage with an outperform rating.
• The stock was trading down 1.6% at $29.51, and insider selling has been notable, including a large sale by Bain Capital Life Sciences. The company also has a market cap of about $2.54 billion.

Shares of Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) have been given a consensus rating of "Moderate Buy" by the nine ratings firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $37.6667.

Several analysts have recently commented on the stock. JPMorgan Chase & Co. reduced their price target on shares of Heartflow from $40.00 to $35.00 and set an "overweight" rating on the stock in a research report on Thursday, March 19th. Canaccord Genuity Group lifted their price target on shares of Heartflow from $40.00 to $43.00 and gave the company a "buy" rating in a research report on Thursday, March 19th. William Blair began coverage on shares of Heartflow in a research report on Monday, May 4th. They set an "outperform" rating on the stock. Finally, Wells Fargo & Company reduced their price objective on shares of Heartflow from $38.00 to $35.00 and set an "overweight" rating on the stock in a report on Thursday, March 19th.

Heartflow Stock Down 1.6%

NASDAQ HTFL opened at $29.51 on Friday. The firm has a market cap of $2.54 billion and a PE ratio of -14.83. The business's fifty day simple moving average is $26.52 and its 200-day simple moving average is $29.13. Heartflow has a 52 week low of $20.13 and a 52 week high of $41.22.

Insider Activity at Heartflow

In related news, major shareholder Bain Capital Life Sciences Inv sold 948,757 shares of the business's stock in a transaction dated Thursday, April 30th. The shares were sold at an average price of $29.23, for a total value of $27,732,167.11. Following the sale, the insider directly owned 8,448,158 shares in the company, valued at approximately $246,939,658.34. The trade was a 10.10% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Campbell Rogers sold 64,533 shares of the business's stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $24.64, for a total value of $1,590,093.12. Following the completion of the sale, the insider directly owned 81,002 shares in the company, valued at approximately $1,995,889.28. The trade was a 44.34% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,271,027 shares of company stock valued at $65,724,873 in the last quarter.

Institutional Trading of Heartflow

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. TrueMark Investments LLC raised its position in Heartflow by 1.4% in the first quarter. TrueMark Investments LLC now owns 26,885 shares of the company's stock valued at $654,000 after purchasing an additional 379 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in Heartflow during the fourth quarter worth about $27,000. TFC Financial Management Inc. purchased a new stake in Heartflow during the third quarter worth about $40,000. Strs Ohio increased its stake in Heartflow by 35.3% during the first quarter. Strs Ohio now owns 4,600 shares of the company's stock worth $112,000 after purchasing an additional 1,200 shares during the period. Finally, Russell Investments Group Ltd. purchased a new stake in Heartflow during the fourth quarter worth about $45,000.

About Heartflow

HeartFlow, Inc NASDAQ: HTFL is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company's core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow's analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow's cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.